This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Celltrion Inc.. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Hye Young Kang: Innovator in Pharmaceutical Formulations
Introduction
Hye Young Kang is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable liquid formulations for antibodies. With a total of three patents to his name, Kang's work is recognized for its innovative approaches to enhancing the stability and efficacy of pharmaceutical products.
Latest Patents
Kang's latest patents include a "Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine." This patent discloses a stable liquid formulation that includes an antibody or antigen-binding portion, an acetate buffer, glycine, and a surfactant. Notably, this formulation does not contain sugar, sugar alcohol, or metal salt, yet remains stable even with high antibody content, making it suitable for subcutaneous administration. Another significant patent is the "Stable liquid pharmaceutical preparation," which describes a formulation that includes an antibody or antigen-binding fragment, a surfactant, a sugar or sugar derivative, a buffer, and a stabilizer. This formulation is characterized by low viscosity and superior long-term storage stability, even under harsh conditions.
Career Highlights
Hye Young Kang is currently employed at Celltrion Inc., a leading biopharmaceutical company. His work at Celltrion focuses on developing innovative solutions for pharmaceutical formulations, contributing to the advancement of medical treatments.
Collaborations
Kang collaborates with talented colleagues, including Joon Won Lee and Yeon Kyeong Shin, who bring diverse expertise to their projects. Their teamwork enhances the innovative capacity of their research and development efforts.
Conclusion
Hye Young Kang's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of the complexities involved in creating stable and effective medical solutions.